ロード中...
Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1
Fusobacterium nucleatum (F. nucleatum) is an oral anaerobe found to be enriched in colorectal cancer (CRC). Presence of F. nucleatum in CRC has been correlated with resistance to chemotherapy and poor prognosis. We previously demonstrated that the Fap2 outer-surface protein of F. nucleatum binds and...
保存先:
| 出版年: | Oncoimmunology |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492956/ https://ncbi.nlm.nih.gov/pubmed/31069151 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2019.1581531 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|